Cryofocus Medtech (Shanghai) Co (HKSE:06922) Total Liabilities: HK$98.24 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:06922 Cryofocus Medtech (Shanghai) Co Ltd HKSE:06922
61 GF Score
Price HK$2.79
GF Value HK$21.01
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Cryofocus Medtech (Shanghai) Co Total Liabilities?

Cryofocus Medtech (Shanghai) Co HKSE:06922 +4.89% 61 Total Liabilities is HK$98.24 Mil as of Dec. 2025. GuruFocus rates HKSE:06922 with a GF Score™ of 61/100 and a GF Value™ of HK$21.01 (Possible Value Trap). The stock has 3 warning signs investors should review.

Cryofocus Medtech (Shanghai) Co's Total Liabilities for the quarter that ended in Dec. 2025 was HK$98.24 Mil.

Cryofocus Medtech (Shanghai) Co's quarterly Total Liabilities increased from Dec. 2024 (HK$75.07 Mil) to Jun. 2025 (HK$109.95 Mil) but then declined from Jun. 2025 (HK$109.95 Mil) to Dec. 2025 (HK$98.24 Mil).

Cryofocus Medtech (Shanghai) Co's annual Total Liabilities increased from Dec. 2023 (HK$43.05 Mil) to Dec. 2024 (HK$75.07 Mil) and increased from Dec. 2024 (HK$75.07 Mil) to Dec. 2025 (HK$98.24 Mil).

Cryofocus Medtech (Shanghai) Co Total Liabilities Historical Data

* Premium members only.

The historical data trend for Cryofocus Medtech (Shanghai) Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cryofocus Medtech (Shanghai) Co Total Liabilities Chart

Cryofocus Medtech (Shanghai) Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial 42.48 60.83 43.05 75.07 98.24

Cryofocus Medtech (Shanghai) Co Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 63.10 75.07 109.95 98.24 117.31
HKSE:06922
61GF Score
Cryofocus Medtech (Shanghai) Co Ltd HKSE:06922
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cryofocus Medtech (Shanghai) Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Cryofocus Medtech (Shanghai) Co's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=66.549+(4.108+8.899
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+18.681)
=98.24

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=151.852-53.616
=98.24

Cryofocus Medtech (Shanghai) Co's Total Liabilities for the quarter that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=66.549+(4.108+8.899
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+18.681)
=98.24

Total Liabilities=Total Assets (Q: Dec. 2025 )-Total Equity (Q: Dec. 2025 )
=151.852-53.616
=98.24

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of HK$98.24 Mil mean?
Cryofocus Medtech (Shanghai) Co (HKSE:06922) has a Total Liabilities of HK$98.24 Mil as of Dec. 2025. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Cryofocus Medtech (Shanghai) Co and its competitors.
Is Cryofocus Medtech (Shanghai) Co's Total Liabilities too high?
Cryofocus Medtech (Shanghai) Co's current Total Liabilities is HK$98.24 Mil. Overall, Cryofocus Medtech (Shanghai) Co has a GF Score™ of 61/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Cryofocus Medtech (Shanghai) Co's Total Liabilities compare to ABT and SYK?
Cryofocus Medtech (Shanghai) Co's Total Liabilities of HK$98.24 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Medical Devices & Instruments company?
A good Total Liabilities depends on the Medical Devices & Instruments industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Cryofocus Medtech (Shanghai) Co and its competitors. Cryofocus Medtech (Shanghai) Co's current Total Liabilities is HK$98.24 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cryofocus Medtech (Shanghai) Co stock overvalued right now?
Based on GuruFocus' analysis, Cryofocus Medtech (Shanghai) Co (HKSE:06922) is currently considered Possible Value Trap. The stock's GF Value™ is HK$21.01, compared to a current price of HK$2.79 — trading 86.7% below its estimated fair value. The current Total Liabilities is HK$98.24 Mil. Cryofocus Medtech (Shanghai) Co's overall GF Score™ is 61/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Cryofocus Medtech (Shanghai) Co (HKSE:06922), the current Total Liabilities is HK$98.24 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cryofocus Medtech (Shanghai) Co (HKSE:06922) Overvalued in 2026?

Based on GuruFocus' analysis, Cryofocus Medtech (Shanghai) Co stock appears to be undervalued. The current stock price of HK$2.79 is trading 86.7% below its estimated GF Value™ of HK$21.01. GuruFocus considers Cryofocus Medtech (Shanghai) Co to be Possible Value Trap.

Key valuation signals for HKSE:06922:

  • Total Liabilities: HK$98.24 Mil
  • GF Value™: HK$21.01 vs. price of HK$2.79 (86.7% below fair value)
  • GF Score™: 61/100 with 3 warning signs

No single metric tells the full story. See the HKSE:06922 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cryofocus Medtech (Shanghai) Co Business Description

Address Lane 3399, Kangxin Road, Building 15, Pudong New Area, Shanghai, CHN, 200120
Cryofocus Medtech (Shanghai) Co Ltd is a medical device company engaged in the research and development, manufacture, and sale of cryoablation minimally invasive interventional treatment technology and related medical products. The company uses liquid nitrogen as the main cryogenic source for cryotherapy systems by leveraging liquid nitrogen cryoablation technology and flexible catheter technology. The products offered by the company include: Bladder Cryoablation System, Pulmonary Nodule Localization Needle, and Endoscopic Clip for Anastomosis, among others. Geographically, the company's revenue is generated from the sale of medical consumables and devices in the Chinese Mainland.
61GF Score

Get the complete analysis for HKSE:06922

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$2.79
Price
HK$21.01
GF Value